Trial Profile
A Randomised Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated Cirrhosis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Mar 2023
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B; Liver cirrhosis
- Focus Adverse reactions; Therapeutic Use
- 18 Sep 2014 New trial record